admin
Experts from the specialty will address the sessions on different topics related to gall bladder cancer
India
healthysoch
New Delhi, February 25, 2023:
Indraprastha Apollo Hospital is pleased to announce the upcoming event on gall bladder cancer organized by Dr. Dipanjan Panda, Senior Consultant, Medical Oncologist, Indraprastha Apollo Hospital, New Delhi. This event aims to create awareness among the public and medical professionals regarding Epidemiology, pathogenesis and molecular biology, diagnosis, and management of gallbladder cancer.
The event will take place on 25th February 2023 from 9:30 onwards, at The Auditorium, Indraprastha Apollo Hospital. The program will include 13 informative sessions on various topics related to gall bladder cancer, along with a panel discussion featuring eminent experts in the field. As per the latest Globocan 2020 data the incidence and mortality of gall bladder cancer globally is almost 1.85 lakh and 85000 respectively making it one of the most lethal cancer. India has one of the highest incidence of gall bladder cancer in the world. India is a high incidence area for gallbladder cancer (GBC) and contributes to about 10% of the global GBC burden.
Speaking about the initiative Dr. Dipanjan Panda, Senior Consultant, Medical Oncologist, Indraprastha Apollo Hospital, New Delhi said, “We are looking forward to bringing together experts from the field of gall bladder cancer to share their knowledge and experience with the attendees. Through this event, we hope to create awareness among the public and medical professionals regarding the diagnosis, and treatment of gall bladder cancer.”
The sessions will cover a wide range of topics, including the latest advancements in the diagnosis of gall bladder cancer, treatment options, and overall management strategies. The sessions will be conducted by renowned specialists in their fields, who will share their knowledge and experience.
Gall Bladder Cancer in India usually affects younger patients in the 5th and 6th decade in contrast to the west. Gallstones are present in 80% of the Indian patients with Gall Bladder Cancer and its presence increases the vulnerability of the Gall Bladder to mucosal injury. The incidence of Gall Bladder Cancer is out of proportion to the prevalence of gallstones in the country. Additional co-factors such as older age, lower socio-economic status, chronic Salmonella Typhi (S. Typhi) infection, Helicobacter pylori (H. pylori) infection, exposure to pollutants, heavy metals, chemicals, adulterated mustard oil and smoking in patients with gallstones have been identified which promote carcinogenesis.
Detected early gall bladder cancer can potentially be cured with radical surgery followed by adjuvant chemotherapy and radiation. However only a small number (less than ten percent) is detected early, making a risk stratified effective screening programme a matter of utmost importance. Advanced cancer is managed with chemotherapy, targeted therapy and immunotherapy which is one of the newest arsenal in our hand.
However, considering the poor prognosis of advance disease early detection is of utmost importance, large multi centric comprehensive studies are required in India to assess the attributable risk of each of the identified risk factors. This will help in formulating cost effective national strategies in preventing Gall bladder cancer related mortality in the country. Meanwhile a high index of suspicion to pick up incidental GBC, and improved access to healthcare facilities to manage Gall Stone appropriately will help in reducing GBC related mortality.
healthysoch
HealthySoch
